跳转至内容
Merck
  • Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use.

Evaluation and management of acquired methemoglobinemia associated with topical benzocaine use.

American journal of cardiovascular drugs : drugs, devices, and other interventions (2013-05-23)
Mohammed Taleb, Zubair Ashraf, Shahul Valavoor, Jodi Tinkel
摘要

Benzocaine is a widely used topical oropharyngeal anesthetic and has been reported to cause methemoglobinemia. We discuss benzocaine-induced methemoglobinemia and review the causes, presentation, and management of this serious complication. Treatment with methylene blue will result in reversal of methemoglobinemia and clinical recovery in most cases but needs to be used at appropriate doses in carefully selected individuals. Physicians who perform procedures involving the application of benzocaine for topical anesthesia need to rapidly identify and treat methemoglobinemia to avoid significant associated morbidity and mortality.

材料
货号
品牌
产品描述

Sigma-Aldrich
苯佐卡因, ≥99% (HPLC)
Sigma-Aldrich
4-氨基苯甲酸乙酯, 98%
Supelco
苯佐卡因, Pharmaceutical Secondary Standard; Certified Reference Material
苯佐卡因, European Pharmacopoeia (EP) Reference Standard